The use of national reimbursement reports to support formulary decisions of the hospital's Drug and Therapeutics Committee: a comparative analysis.

Claus, Barbara; Commeyne, Sabrina; Van de Casteele, Marc; Rottey, Sylvie

Claus, Barbara; Commeyne, Sabrina; Van de Casteele, Marc; Rottey, Sylvie.

Afiliación

Claus B; Pharmacy Department, Ghent University Hospital, Ghent, Belgium. Barbara.claus@ugent.be.
Commeyne S; Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium. Barbara.claus@ugent.be.
Van de Casteele M; Pharmacy Department, Ghent University Hospital, Ghent, Belgium.
Rottey S; National Institute for Health and Disability Insurance, Brussels, Belgium.

Int J Clin Pharm ; 44(3): 769-774, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35199288

Asunto(s)

Comité Farmacéutico y Terapéutico; Proyectos de Investigación; Bélgica; Hospitales; Humanos; Estudios Retrospectivos

Palabras clave

Access to treatment; Availability; Drug and Therapeutics Committee; Drug reimbursement; Formulary; Health technology assessment; Hospital; Innovative; National; Orphan; Patient access; Unmet need

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Comité Farmacéutico y Terapéutico / Proyectos de Investigación Tipo de estudio: Health_technology_assessment / Observational_studies / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Int J Clin Pharm Año: 2022 Tipo del documento: Article País de afiliación: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google